TORONTO (PRWEB) May 12, 2022
Keith Lane, Vice President, Ora Posterior Segment; and Dr. Sally Tucker, Vice President, Ora Europe, will share insights and strategies for improving clinical study success, navigating development program hurdles, and embracing innovation on front lines of the rapidly expanding field of retinal therapeutics.
Topics to be covered include improving study success rates through global-to-local operations models, how to assess meaningful quality of life (QOL) impact of potential therapies by innovating novel endpoints beyond traditional visual acuity, how to effectively demonstrate efficacy and impact while creating therapy differentiation; and leveraging clinical trial advocacy to create study awareness and accessibility.
With current projections suggesting exponential acceleration in retina programs over the next decade, they will also discuss the current industry landscape, future milestones, and the latest advancements fueling unapparelled opportunities for researchers and a brighter future for patients around the world.
This live webinar will be held on Wednesday, June 1, 2022, at 10am EST (3pm GMT/UK). For more information, or to register for this free event, visit: Revolutions in Retina Research: How to Be at The Forefront of Research in The Back of The Eye.
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 55 product approvals and create vision beyond what they see. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and operations management to maximize the value of new product initiatives. Think ophthalmology, think Ora. For more information, please visit http://www.oraclinical.com, like us on Facebook, and follow us on LinkedIn.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.